18th IBD Intensive Advanced Course

Date       February 12-13, 2020
Time   February 12 from 08:00 to 17:00
February 13 from 07:30 to 12:00
Responsible Committee   EduCom
Target audience   Junior gastroenterologists
ECCO Membership 2020 required   Regular/Y-ECCO Membership
Registration details   pdfCall for participants: 18th IBD Intensive Advanced Course at ECCO'20
Registration fee and further details coming soon

  • 18th IBD Intensive Advanced Course
    08:00-08:15 Arrival and distribution of voting pads
    08:15–08:30 1: Welcome & Introduction from the course director
    08:30–10:30 Session 1: Introduction and case-based management on conventional IBD Therapies
    08:30-09:00 2: IBD: Epidemiology, immunopathogenesis, and their relevance to therapeutics
    09:00-09:20 3: 5-ASA compounds
    09:20-09:40
    4: Thiopurines
      09:40-10:00
    5: Methotrexate
      10:00-10:20 6: Steroids
      10:20-10:30 Discussion
    10:30-10:50 Coffee break
    10:50-12:30 Session 2: Case-based management of conventional IBD therapies
    10:50-11:10 7: Anti-TNF agents
    11:10-11:30 8: Anti-integrins
      11:30-11:50 9: Ustekinumab
      11:50-12:10 10: Tofacitinib
      12:10-12:30 11: Small molecules and biologics in the pipeline
    12:30–14:00 Lunch break
    14:00-15:30 Session 3: Round tables - 7 Themes/clinical cases discussion
    14:00-15:30 12a: Pregnancy
    12b: Extraintestinal manifestations
    12c: When and how to stop biologics?
    12d: Complications associated with anti-TNF therapy

    12e: Therapeutic Drug Monitoring
    12f: Exit strategy
    12g: Therapeutic Endoscopy in IBD
    15:30-15:50 Coffee break
    15:50-17:00 Session 3: Round tables - 7 Themes/clinical cases discussion
      15:50-17:00 12a: Pregnancy
    12b: Extraintestinal manifestations
    12c: When and how to stop biologics?
    12d: Complications associated with anti-TNF therapy

    12e: Therapeutic Drug Monitoring
    12f: Exit strategy
    12g: Therapeutic Endoscopy in IBD
  • 18th IBD Intensive Advanced Course
    07:30-09:30 Session 4: Interactive case discussions
    07:30-08:00 13: Investigation and management of early Mild/Moderate Crohn's Disease
    08:00-08:05 Discussion 
    08:05–08:40 14: Management of perianal CD
    08:40-08:45 Discussion
      08:45-09:30 15: Optimal management of patient with Severe Crohn's Disease treated with anti-TNF agents
    09:30-09:45 Coffee break
    09:45-11:45 Session 5: Special case scenarios
    09:45–10:15 16: Management of Acute Severe Ulcerative Colitis
      10:15-10:45 17: Management of refractory pouchitis
      10:45-11:15 18: Pre- and postoperative management of Crohn's Disease
    11:15-11:45 Discussion
    11:45-12:00 19: Feedback & Closing remarks